Cube Labs SpA (MIL:CUBE) Common Stock : €0.57 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cube Labs SpA Common Stock?

Cube Labs SpA's quarterly common stock increased from Jun. 2022 (€0.35 Mil) to Dec. 2022 (€0.50 Mil) and increased from Dec. 2022 (€0.50 Mil) to Jun. 2023 (€0.57 Mil).

Cube Labs SpA's annual common stock increased from Dec. 2020 (€0.30 Mil) to Dec. 2021 (€0.33 Mil) and increased from Dec. 2021 (€0.33 Mil) to Dec. 2022 (€0.50 Mil).

Cube Labs SpA Common Stock Historical Data

The historical data trend for Cube Labs SpA's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cube Labs SpA Common Stock Chart

Cube Labs SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Common Stock

0.05

0.06

0.30

0.33

0.50

Cube Labs SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Common Stock	Get a 7-Day Free Trial			-	0.33	0.35	0.50	0.57

Cube Labs SpA Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Cube Labs SpA (MIL:CUBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Cube Labs SpA (MIL:CUBE) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Giulio Caccini, 1, Rome, ITA, 00186

Website

https://cube-labs.com

Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for the market.